| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3282536 | Clinical Gastroenterology and Hepatology | 2014 | 7 Pages |
Abstract
Patients with CF-LVADS receiving anticoagulants have a significantly higher risk of GIB and thromboembolic events than patients receiving anticoagulants after cardiac valve replacement surgery. GI angiodysplastic lesions are the most common source of bleeding.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Charles W. Shrode, Karen V. Draper, Robert J. Huang, Jamie L.W. Kennedy, Adam C. Godsey, Christine C. Morrison, Vanessa M. Shami, Andrew Y. Wang, John A. Kern, James D. Bergin, Gorav Ailawadi, Dipanjan Banerjee, Lauren B. Gerson, Bryan G. Sauer,